FDA Inspection
USpharma, Ltd., Co.USpharma, Ltd., Co. – FDA Inspection, May 11, 2010
Record Details
This FDA Inspection record concerns USpharma, Ltd., Co., with an inspection on May 11, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- USpharma, Ltd., Co.
- Inspection Date
- May 11, 2010
- Product Type
- Drugs
View Company Profile
ID · 42198170-d1d8-44ed-8b6a-87d21051e7c1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 662340
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.84(b)Representative Samples
Full citation text and observation details available on the Dashboard.
Other FDA inspections of USpharma, Ltd., Co.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2026 | VAI | Florida District Office | Drug Quality Assurance |
| September 1, 2026 | Not classified | Florida District Office | |
| May 11, 2023 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| February 16, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for USpharma, Ltd., Co.
- FDA Inspection 1334262 - 2026-09-03
- FDA Inspection 1334958 - 2026-09-01
- FDA Inspection 1205546 - 2023-05-11
- FDA Inspection 1198249 - 2023-02-16
- FDA Inspection 1172561 - 2022-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.